|Home | About | Journals | Submit | Contact Us | Français|
ROCK (Rho-kinase), an effector molecule of RhoA, phosphorylates the myosin binding subunit (MBS) of myosin phosphatase and inhibits the phosphatase activity. This inhibition increases phosphorylation of myosin light chain (MLC) of myosin II, which is suggested to induce RhoA-mediated assembly of stress fibers and focal adhesions. ROCK is also known to directly phosphorylate MLC in vitro; however, the physiological significance of this MLC kinase activity is unknown. It is also not clear whether MLC phosphorylation alone is sufficient for the assembly of stress fibers and focal adhesions.
We have developed two reagents with opposing effects on myosin phosphatase. One is an antibody against MBS that is able to inhibit myosin phosphatase activity. The other is a truncation mutant of MBS that constitutively activates myosin phosphatase. Through microinjection of these two reagents followed by immunofluorescence with a specific antibody against phosphorylated MLC, we have found that MLC phosphorylation is both necessary and sufficient for the assembly of stress fibers and focal adhesions in 3T3 fibroblasts. The assembly of stress fibers in the center of cells requires ROCK activity in addition to the inhibition of myosin phosphatase, suggesting that ROCK not only inhibits myosin phosphatase but also phosphorylates MLC directly in the center of cells. At the cell periphery, on the other hand, MLCK but not ROCK appears to be the kinase responsible for phosphorylating MLC. These results suggest that ROCK and MLCK play distinct roles in spatial regulation of MLC phosphorylation.
Phosphorylation of regulatory light chain (MLC) of myosin II plays a critical role in controlling actomyosin contractility in both smooth muscle and nonmuscle cells (Kamm and Stull 1985; Moussavi et al. 1993; Somlyo and Somlyo 1994). MLC phosphorylation is regulated by the balance of two enzymatic activities, i.e., myosin light chain kinase(s) and myosin phosphatase. Myosin light chain kinase (MLCK) is regulated by Ca2+/calmodulin and is believed to be a major kinase in both smooth muscle and nonmuscle cells. Heterotrimeric myosin phosphatase is thought to be a major phosphatase in smooth muscle and perhaps in nonmuscle cells (Hartshorne et al. 1998).
The holoenzyme of myosin phosphatase consists of three subunits: a large subunit of ~130 kD with myosin binding ability (called MBS here), a catalytic subunit of 38 kD (PP1cδ), and a small subunit of 20 kD of unknown function (Alessi et al. 1992; Shimizu et al. 1994; Shirazi et al. 1994). MBS is a critical subunit as it can bind both myosin and the catalytic subunit, thus targeting the substrate, myosin, with the phosphatase. Without MBS, the catalytic subunit, PP1cδ, shows rather weak phosphatase activity toward phosphorylated myosin (Alessi et al. 1992; Hirano et al. 1997; Johnson et al. 1997). The activity of MBS is regulated by phosphorylation with various kinases including protein kinase A, ROCK (Rho-kinase) and unidentified kinases (Ichikawa et al. 1996b; Ito et al. 1997; Totsukawa et al. 1999). For example, ROCK is shown to phosphorylate MBS in the COOH-terminal region including Thr 697 and Ser 854 (Kimura et al. 1996; Feng et al. 1999a; Kawano et al. 1999), resulting in the inhibition of phosphatase activity. This inhibition is suggested to be responsible for the RhoA-mediated Ca2+-sensitization process in smooth muscle (Somlyo and Somlyo 1994; Hartshorne et al. 1998).
The ROCK-mediated inhibition of myosin phosphatase is also suggested to cause RhoA-mediated assembly of stress fibers and focal adhesions in nonmuscle cells (Chrzanowska-Wodnicka and Burridge 1996; Kimura et al. 1996; Kawano et al. 1999). The inhibition of myosin phosphatase appears to account for an increase in MLC phosphorylation seen during serum stimulation of serum-starved 3T3 cells, and the resultant contractility of actomyosin is proposed to induce stress fibers and focal adhesions (Chrzanowska-Wodnicka and Burridge 1996). Indeed, BDM, an inhibitor of actomyosin contractility, was shown to inhibit assembly of stress fibers and focal adhesions during serum stimulation of 3T3 cells (Chrzanowska-Wodnicka and Burridge 1996). Furthermore, a constitutively active form of ROCK induced stress fibers and focal adhesions (Leung et al. 1996; Amano et al. 1997; Ishizaki et al. 1997), though the morphology of stress fibers is stellar and somewhat different from that of stress fibers induced by constitutively active Rho or lysophosphatidic acid. It remains to be elucidated, however, whether MLC phosphorylation alone is responsible for the induction of stress fibers and focal adhesions, because ROCK is known to phosphorylate other substrates including moesin, adducin and intermediate filament proteins (Kosako et al. 1997; Fukata et al. 1998; Kimura et al. 1998). In addition to the inhibition of myosin phosphatase, ROCK has also been reported to directly phosphorylate MLC in vitro (Amano et al. 1996). The physiological significance of this MLC kinase activity remains to be established. If ROCK indeed functions as an MLC kinase, it is then important to determine how the two MLC kinases, ROCK and MLCK regulate MLC phosphorylation in the same cell.
To investigate the physiological functions of myosin phosphorylation in RhoA-mediated assembly of stress fibers and focal adhesions, we have generated two reagents with opposing effects on myosin phosphatase activities. One is an antibody against MBS that is able to inhibit the phosphatase activity of myosin phosphatase. The other is a constitutively active mutant of MBS. Because the mutant lacks the COOH-terminal region that contains the regulatory phosphorylation sites, it constitutively activates myosin phosphatase. Microinjection of these two reagents followed by immunofluorescence with an antibody specific to phosphorylated MLC has allowed us to evaluate MLC phosphorylation with single cells and to examine its roles in microfilament assembly. We have found that MLC phosphorylation is essential and sufficient for the formation of stress fibers and focal adhesions in 3T3 fibroblasts. Our results with the combined use of the inhibitory antibody and an inhibitor of ROCK indicate that ROCK is likely to phosphorylate MLC directly. This MLC kinase activity and the inhibition of myosin phosphatase are both essential for the assembly of stress fibers in the center of cells. MLCK, on the other hand, is involved in microfilament assembly in the cell periphery, indicating that ROCK and MLCK have distinct roles in spatial regulation of MLC phosphorylation.
The polyclonal antibody against MBS (termed M130Ab) was raised in rabbits against the bacterially expressed truncated protein of chicken MBS containing residues 1–296 (Ichikawa et al. 1996a), and affinity purified using the same truncated protein. A monoclonal antibody against Ser 19-phosphorylated MLC was described previously (Sakurada et al. 1998). A monoclonal antibody against vinculin was purchased from Sigma-Aldrich. A monoclonal antibody against paxillin and a monoclonal antibody against FAK were purchased from Transduction Laboratories. A polyclonal goat antibody against MLCK (a kind gift by Dr. de Lanerolle, University of Illinois, Chicago, IL) was prepared and affinity purified as described previously (de Lanerolle et al. 1987). Y-27632, a specific inhibitor of ROCK, was kindly provided by Yoshitomi Pharmaceutical Industries, Ltd. (Osaka, Japan) and ML-9 was purchased from Calbiochem-Novabiochem. Y-27632 and ML-9 were stored as 3 mM stock solution in DMSO in −80°C before use.
Trimeric myosin phosphatase was purified from chicken gizzard according to the method of Alessi et al. 1992. Regulatory light chain of myosin II (MLC) was purified from bovine lung myosin II as described (Sellers 1991). Bacterial expression of truncated MBS proteins, residues 1–296 (called MBS296) and residues 278–415 (MBS278-415), was performed essentially as described except that guanidine hydrochloride was omitted (Hirano et al. 1997; Totsukawa et al. 1999). As the MBS296 protein tended to aggregate during storage, microinjection experiments were performed within 2–3 d after purification.
Balb/c 3T3 fibroblasts were maintained in DME containing 10% calf serum in an atmosphere of 5% CO2 and 95% air at 37°C. Epithelial type normal rat kidney cells (NRK, ATCC CRL 1571) and REF-2A cells (SV-40–transformed REF52 cells) were maintained in DME containing 10% newborn calf serum. Serum-starved 3T3 cells were prepared by culturing subconfluent Balb/c 3T3 cells for 3–5 d in DME without serum. To prepare serum-starved 3T3 cells that were well separated from each other, starved 3T3 cells were replated as follows: cells were detached by trypsinization and trypsin was neutralized with 0.5 mg/ml soybean trypsin inhibitor (Sigma-Aldrich) and 1% BSA. After washing with DME, cells were replated on poly-l-lysine-coated coverslips, and allowed to attach to coverslips for 2 h before microinjection.
Microinjection was performed as described (Yamakita et al. 1990). The antibody (M130Ab, 5 mg/ml) and the truncated proteins (MBS296, 1 mg/ml; MBS278-415, 2 mg/ml) were dialyzed against injection buffer (10 mM potassium phosphate and 70 mM KCl, pH 7.2). FITC-dextran (Molecular Probes) was comicroinjected to identify injected cells. In some experiments, antibody-injected cells were detected by Alexa 350–conjugated anti-rabbit secondary antibody (Molecular Probes). After microinjection of the antibody, serum-starved cells were incubated for 30 min to 2 h before fixation unless otherwise mentioned. In the microinjection experiments with truncated MBS mutants, microinjected cells were incubated for 30 min followed by serum stimulation for 10 min before fixation. In some experiments, 10 μM Y-27632 or 10 μM ML-9 was added 30 min before microinjection. Microinjection was also performed with 3T3 cells growing exponentially in the presence of serum. Each microinjection experiment was performed at least three times.
Immunofluorescence was performed as described previously (Matsumura et al. 1998). Rhodamine-conjugated phalloidin was used for F-actin staining. Phase and fluorescence images were taken with an AT200 cooled CCD camera (Photometric) and processed with a MicroTome image processing software (VayTek; Fairfield).
Trimeric myosin phosphatase (38 nM) was first incubated with various concentrations of M130Ab for 30 min on ice and then phosphatase activities were assayed at room temperature for 5 min with 32P-labeled MLC (5 μM) in 30 mM Tris-HCl (pH 7.5), 0.1 M KCl, 2 mM MgCl2, and 0.1 mg/ml BSA. The reaction was terminated by the addition of trichloroacetic acid and BSA to final concentrations of 10% and 3 mg/ml, respectively. After centrifugation, the radioactivities of the supernatants were determined by Cerenkov counting. 32P-labeled phosphorylase was also used as a substrate instead of MLC.
Immunoblotting was performed as described previously (Totsukawa et al. 1999). Immunoreactive bands were detected with peroxidase-conjugated secondary antibody using a chemiluminescence method (NEN). SDS-PAGE was performed as described by Blatter et al. (Blatter et al. 1972) using 12.5% polyacrylamide gel and the Laemmli buffer system (Laemmli 1970). Protein concentrations were determined by the method of Bradford (Bradford 1976) using BSA as standard.
To generate an antibody that is able to inhibit myosin phosphatase, we chose the NH2-terminal region (1–296) of chick MBS as an antigen. This region is critical for the functions of MBS because it is responsible for the binding to both the catalytic subunit of PP1cδ and the substrate, myosin (Hirano et al. 1997). As Fig. 1 a shows, the antibody (termed M130Ab) specifically reacts with MBS from a variety of nonmuscle cells including REF2A cells (lane 1), 3T3 cells (lane 2) and NRK cells (lane 3). Fig. 1 b shows the effect of M130Ab on myosin phosphatase activity using phosphorylated MLC as a substrate. The antibody, at a concentration of 1.7 μM, is able to inhibit myosin phosphatase activity to less than 34% of that in the absence of the antibody. When phosphorylated phosphorylase is used as a substrate, the antibody does not show any inhibition (data not shown).
We microinjected the antibody into serum-starved 3T3 cells to see whether the inhibition of myosin phosphatase results in increased MLC phosphorylation and whether an elevation of MLC phosphorylation (if any) induces the assembly of stress fibers and focal adhesions without serum stimulation. As a control, preimmune antibody was injected. As Fig. 2 shows, phalloidin staining reveals that cells microinjected with M130Ab form parallel or stellar stress fibers (Fig. 2, a–d) while the control injection with preimmune antibody has no effect (data not shown). Concomitantly, MLC phosphorylation of injected cells is found to be greatly increased (Fig. 2e and Fig. f). A monoclonal antibody specific to S19-phosphorylated MLC stains antibody-injected cells strongly while very weak staining is seen with uninjected cells. The induction of stress fibers and concomitant increase in MLC phosphorylation are observed in about 80% of cells injected with the M130Ab (n = 345).
Two types of stress fibers are formed by M130Ab injection. Most (75%) of stress fibers are parallel (Fig. 2c and Fig. d), while the rest exhibit stellar stress fibers radiating from several foci (Fig. 2, a and b). When the concentration of M130Ab is doubled, more cells show stellar stress fibers, suggesting that the formation of stellar stress fibers depends on the extent of inhibition of myosin phosphatase. About 20–50% of MLC is phosphorylated in nonmuscle cells under normal conditions (Yamakita et al. 1994; Kolega and Kumar 1999). These cells have well developed stress fibers, indicating that partial MLC phosphorylation is sufficient for the formation of stress fibers. It is possible that the higher concentrations of M130Ab cause more complete inhibition of myosin phosphatase and thus increase MLC phosphorylation above the levels observed under normal conditions. This may result in the formation of stellar stress fibers. Similar stellar stress fibers were induced by overexpression of constitutively active ROCK (Leung et al. 1996; Amano et al. 1997; Ishizaki et al. 1997). It is likely that constitutively active ROCK would also lead to unusually high levels of MLC phosphorylation via extensive inhibition of myosin phosphatase.
The inhibition of myosin phosphatase by M130Ab injection also induces focal adhesion assembly (Fig. 3). About 80% of injected cells show higher staining with antibodies against components of focal adhesions including vinculin (Fig. 3, a and b; n = 190), paxillin (Fig. 3c and Fig. d; n = 114) and FAK (Fig. 3e and Fig. f; n = 132). Double staining with rhodamine-conjugated phalloidin (Fig. 3 h) and the anti-vinculin antibody (Fig. 3 i) reveals that vinculin staining is concentrated at the ends of or along stress fibers, indicating that focal adhesions are indeed formed (Fig. 3 j). These observations indicate that the inhibition of myosin phosphatase increases MLC phosphorylation, and suggest that the increase is sufficient to induce both stress fibers and focal adhesions. They also indicate that the heterotrimeric myosin phosphatase is a major phosphatase controlling MLC phosphorylation in 3T3 cells.
A constitutively active mutant of MBS would be a useful tool to examine whether the inhibition of MLC phosphorylation blocks the RhoA-mediated induction of stress fibers and focal adhesions. We speculated that the NH2 terminus of MBS spanning residues 1–296 (MBS296) would behave as a constitutively active mutant for the following reasons. First, MBS296 when combined with PP1cδ has increased myosin phosphatase activity compared with PP1cδ alone (Hirano et al. 1997). This reflects the binding of MBS296 to both myosin and PP1cδ. Second, MBS296 may be able to associate with PP1cδ because cells have a large pool of PP1cδ (Fernandez et al. 1992; Andreassen et al. 1998). Third and most importantly, MBS296 does not contain the inhibitory phosphorylation sites. While myosin phosphatase activity is inhibited by phosphorylation of MBS, the inhibitory phosphorylation sites so far reported are located towards the COOH terminus of MBS. For example, Rho-kinase phosphorylates Thr 697 and Ser 854 (Kawano et al. 1999) and recently phosphorylation at Thr 697 has been shown to be responsible for the inhibition of myosin phosphatase (Feng et al. 1999a). Thus MBS296 would not be phosphorylated following microinjection into cells and would not be subjected to regulation by ROCK.
We microinjected MBS296 into serum-starved 3T3 cells and then stimulated with serum to observe the effects on the assembly of stress fibers and focal adhesions. As Fig. 4 shows, MBS296 microinjection blocks serum-induced stress fiber formation though a network of microfilaments is formed (Fig. 4, a and b; n = 195). Concomitantly, MLC phosphorylation stays very low in injected cells (Fig. 4c and Fig. d; n = 187) while noninjected cells show greatly increased MLC phosphorylation upon serum stimulation (indicated by asterisks). Focal adhesion assembly is also blocked (Fig. 4e and Fig. f; n = 131). As a control, we injected the central region of MBS, residues 278–415, and found no effect on stress fiber formation (Fig. 4g and Fig. h; n = 89) or MLC phosphorylation (Fig. 4i and Fig. j; n = 84). These observations, together with the results of the M130Ab injection, indicate that MLC phosphorylation is both necessary and sufficient for the induction of stress fibers and focal adhesions. The formation of the network of microfilaments in the MBS296-injected cells (arrowhead in Fig. 4 a) indicates that serum-induced actin polymerization is not blocked by MBS296. This observation is consistent with the report by Watanabe et al. 1999 demonstrating that mDia, another RhoA effector, is responsible for the RhoA-induced actin polymerization.
The increase of MLC phosphorylation by inhibition of myosin phosphatase (Fig. 2e and Fig. f) indicates the presence of active MLC kinase(s) in serum-starved cells. MLCK and ROCK are possible candidates. To determine which kinase(s) is involved, serum-starved 3T3 cells were treated, before M130Ab injection, with kinase inhibitors, Y-27632 or ML-9, to inhibit ROCK (Uehata et al. 1997) or MLCK (Saitoh et al. 1987), respectively. As Fig. 5 shows, these inhibitors produce distinctive effects on the microfilament organization in M130Ab-injected cells. The ROCK inhibitor, Y-27632, blocks the formation of stress fibers in the center of injected cells (Fig. 5, a and b; n = 178). Interestingly, however, thick cortical actin bundles are induced along the cell periphery of M130Ab-injected cells (Fig. 5 a). These fibers are stained with the monoclonal antibody against S19-phosphorylated MLC (Fig. 5c and Fig. d; n = 139), and contain focal adhesions as revealed by vinculin staining (Fig. 5e and Fig. f; n = 107). These observations suggest that ROCK is responsible for MLC phosphorylation in the center of cells but not at the cell periphery. Phosphorylation by ROCK of other of its substrates (including moesin, adducin, and intermediate filament proteins) is not required for focal adhesion assembly.
The MLCK inhibitor, ML-9, on the other hand, does not inhibit the formation of M130Ab-induced stress fibers (Fig. 5g and Fig. h; n = 121). The stress fibers are again stained strongly with the monoclonal antibody against S19-phosphorylated MLC (data not shown). These results suggest that MLCK is not a major kinase responsible for stress fiber assembly in the center of 3T3 cells. MLCK, however, seems to be involved in the phosphorylation and assembly of peripheral microfilament bundles. When the two inhibitors are added simultaneously, the peripheral microfilament bundles that are formed in the presence of Y-27632 alone are not induced (Fig. 5i and Fig. j; n = 141).
Similar spatially differentiated regulation by these two kinases is also observed with 3T3 cells growing in the presence of serum. Exponentially growing cells were first treated with either Y-27632 or ML-9, and then M130Ab was injected. As reported previously (Uehata et al. 1997), the treatment with Y-27632 disassembles stress fibers (Fig. 5 k, see uninjected cells indicated by asterisks). Inhibition of myosin phosphatase by microinjection of M130Ab induces the formation of similar peripheral microfilament bundles, but no stress fibers are found in the center (Fig. 5k and Fig. l; n = 150). Unlike Y-27632, treatment with ML-9 does not markedly affect the assembly of stress fibers of 3T3 cells growing in the presence of serum (Fig. 5 m, see uninjected cells indicated by asterisks). Microinjection of M130Ab, however, frequently produces stellar stress fibers in the center of cells and injected cells seem to be contracted (Fig. 5m and Fig. n; n = 175). This is probably due to an increased inhibition of myosin phosphatase (by M130Ab) in addition to the inhibition induced by ROCK in the presence of serum.
If MLCK is responsible for the formation of peripheral microfilament bundles, MLCK should be localized in such bundles. Serum-starved 3T3 cells were again treated with Y-27632 and injected with the M130Ab to induce peripheral microfilament bundles. To examine the localization of MLCK in 3T3 cells injected with the M130Ab (rabbit antibody), the goat anti-MLCK antibody (de Lanerolle et al. 1987) was used. As Fig. 6, a–c, shows, the peripheral microfilament bundles (arrowheads in b, rhodamine-phalloidin) were stained with the anti-MLCK antibody (arrowheads in c; n = 123). Similar localization of MLCK was found in 3T3 cells grown in the presence of serum (Fig. 6, d–f, n = 95). The anti-MLCK antibody stained peripheral microfilament bundles (e, rhodamine-phalloidin; f, MLCK) though the background of MLCK staining was higher than that seen in the absence of serum. These results support that MLCK is responsible for the phosphorylation of MLC at the cell periphery.
Using the two newly developed reagents with the opposing effects on myosin phosphatase, we have demonstrated that MLC phosphorylation is not only necessary but also sufficient to induce the assembly of stress fibers and focal adhesions. This result strongly supports the model for the assembly of stress fibers and focal adhesions proposed earlier by Burridge and coworkers (Chrzanowska-Wodnicka and Burridge 1996) that myosin II–based contractility is the force that drives the assembly of stress fibers and focal adhesions. The contractility is essential because simple actin bundling by an actin bundling protein such as fascin failed to produce stress fibers when injected into serum-starved 3T3 cells (data not shown).
It is worthy of note that focal adhesion assembly can be induced by MLC phosphorylation alone even when the RhoA/ROCK (Rho-kinase) activity is blocked. Focal adhesions are formed along the peripheral microfilament bundles that are induced by M130Ab injection in the presence of Y-27632 (Fig. 5, a–f). Similar peripheral bundles and focal adhesions are formed in the presence of Toxin B, a bacterial toxin that blocks Rho activity (Just et al. 1994). These results suggest that other RhoA/ROCK-mediated factors (such as phosphorylation of other substrates by ROCK or an elevation of PIP2 levels) may not be essential for focal adhesion assembly. Perhaps, vinculin in serum-starved cells is in a PIP2-bound state. Microfilaments in serum-starved cells are thus likely to stay associated with vinculin and other focal adhesion components but be dispersed due to the lack of active myosin. Activation of myosin would simply bring such microfilaments together to form focal adhesions.
Our results suggest that ROCK's ability to directly phosphorylate MLC is significant in 3T3 cells. This is based on the observation that, when ROCK is blocked by Y-27632, inhibition of myosin phosphatase via microinjection of M130Ab did not form stress fibers in the center of cells (though peripheral microfilament bundles were formed, see Fig. 5). The simplest interpretation of this observation is that the MLC kinase activity of ROCK and its known function of inhibiting myosin phosphatase by phosphorylating MBS are both essential for stress fiber assembly in the center of cells. We can not exclude the possibility, however, that, under different conditions or in other types of cells, MLCK can play a more significant role in MLC phosphorylation than ROCK. This appears to be the case in smooth muscle cells: ROCK functions mainly as an inhibitor of myosin phosphatase under physiological conditions (Iizuka et al. 1999).
Interestingly, we have found that the two different MLC kinases of ROCK and MLCK function at different cellular locations to induce assembly of distinct sets of microfilament bundles in 3T3 cells. As illustrated in Fig. 7, ROCK is involved in the formation of stress fibers in the center of cells, while MLCK functions at the periphery. In the center of cells (a), ROCK controls not only MLC phosphorylation (by direct phosphorylation) but also MLC dephosphorylation (by inhibiting myosin phosphatase). MLCK appears not to be involved in the MLC phosphorylation. At the cell periphery (b), on the other hand, the major role of ROCK is to control MLC dephosphorylation through inhibiting myosin phosphatase. MLCK is likely to be the kinase responsible for MLC phosphorylation. Because the ROCK inhibitor does not affect the assembly of peripheral microfilament bundles, the Rho/ROCK pathway does not appear to regulate MLCK. It should be noted, however, that the spatially differentiated regulation of MLC phosphorylation by these two kinases may vary depending on cell types and contractile activities.
What mechanism could make the two MLC kinases function at different cellular locations? One possibility is that the upstream signals to activate each kinase may work at different locations. For example, if calcium concentration is high at the cell periphery, then MLCK would become preferentially active in such a location. In addition, the difference in their intracellular localizations partly explains the spatially differentiated regulation. ROCK is diffusely localized in the center (or perinuclear) region of cells. While MLCK was reported to be localized on stress fibers (de Lanerolle et al. 1981; Guerriero et al. 1981), a close examination of the work by Guerriero et al. 1981 has revealed that MLCK is localized more prominently on cortical microfilament bundles at the cell periphery of 3T3 cells.
The spatially differentiated regulation by the two MLC kinases is likely to provide a mechanism to regulate MLC phosphorylation in localized regions of the cell and by the different upstream stimuli. In addition, this system would be able to confer very different contractile activities on actomyosin depending on which kinase is responsible. According to the kinetic data (Amano et al. 1996; Feng et al. 1999b), MLCK phosphorylates the substrate 2–7 times more rapidly than does ROCK while the Km of ROCK appears to be 15–20 times lower than that of MLCK. This suggests that MLCK would cause rapid contraction though the higher Km value may require close contact between MLCK and myosin. ROCK, on the other hand, would be able to induce contraction (though more slowly) even if the concentrations of ROCK and myosin are low. Indeed, ROCK is diffusely present throughout the cell. The contractility of peripheral microfilament bundles is thus predicted to be more responsive to the upstream stimuli than that of stress fibers. Future studies should be directed toward elucidating how the two kinases regulate, both in space and time, complex contractile processes such as cell division, neurite retraction and cell migration.
We thank Yoshitomi Pharmaceutical Industries, Ltd. for providing Y-27632; Drs. K. Aktories and F. Hofmann (Institute for Pharmakologie and Ocikologie) for Toxin B; Dr. P. de Laneroll (University of Illinois) for anti-MLCK antibody; and Dr. F. Deis (Rutgers) for critical reading of this manuscript.
This work is supported by the National Institutes of Health grants CA42742 to F. Matsumura and HL23615 to D.J. Hartshorne. F. Matsumura is a member of the Cancer Institute of New Jersey. G. Totsukawa is supported by a fellowship from the Leukemia Research Foundation.
Abbreviations used in this paper: MBS, myosin binding subunit of myosin phosphatase; MLC, regulatory light chain; MLCK, myosin light chain kinase; PP1c, catalytic subunit of type 1 protein phosphatase; ROCK, Rho-associated kinase.